Maryland Woos Away Top Deputy at the FDA

The Washington Post, January 5, 2011. Joshua M. Sharfstein, the second-in-command at the Food and Drug Administration, is leaving that post after less than two years to become Maryland’s top public health official, Gov. Martin O’Malley said Tuesday.

Read More »

Panel Votes to Expand Surgery for Less Obese

New York Times, December 3, 2010. A federal advisory panel Friday endorsed an expansion of the use of Allergan’s Lap-Band stomach-restricting device to patients who are less than severely obese. Where’s the long-term data?

Read More »